We searched Medline with the term “trachoma”. The search was augmented by the extensive libraries of the authors, WHO publications, and searches of key papers by hand. We included papers written in English. There were no date restrictions.
SeminarTrachoma
Introduction
Trachoma is a disease that should stand on the brink of extinction. This blinding scourge has plagued mankind for as long as recorded history. Ancient medical texts from Egypt, China, Rome, Greece, and Arabia all make reference to trachoma.
Trachoma came to prominence in 18th century Europe, when it spread like wildfire through the slums of the industrial revolution. Brought back by troops returning from the Napoleonic wars in Egypt, the Egyptian ophthalmia as it was known rapidly became a major public-health concern and spawned many of the great ophthalmic institutions of Europe and North America. It was such an important public-health concern in the emerging USA that all immigrants who passed through centres such as Ellis Island were checked for trachoma and sent home if they had signs of the disease.
About 100 years ago, many of today's developed countries had trachoma-control activities. However, although the disease has largely disappeared from the developed world as the standard of living and personal and community hygiene has improved, it is still a major issue in poor regions of many developing countries. The WHO Global Alliance for the Global Elimination of Trachoma—GET 2020—promotes the widespread implementation of the SAFE strategy to combat blinding trachoma. SAFE is an acronym for four inter-related public-health interventions: surgery for trichiasis, antibiotics for active trachoma, facial cleanliness, and environmental improvements to reduce transmission. By reducing the reservoir of infection in communities with effective antimicrobial campaigns and decreasing the potential for transmission of infection with facial-cleanliness campaigns, augmented with environmental-health improvements, we can make trachoma history.
Section snippets
Epidemiology
Poor personal and community hygiene are closely associated with extreme poverty and probably promote the transmission of chlamydial infection that leads to trachoma. WHO regards blinding trachoma to be endemic not only in 56 countries of the world, mainly in Africa and the Middle East, but also in parts of Asia, Latin America, and the western Pacific.1 About 84 million people have active trachoma, another 7·6 million have trichiasis,2 and 1·3 million are blind from trachoma.3 A decade ago, 7
Assessment of burden of disease within a population
Establishing the burden of trachoma within a community is important for determining whether a community needs a population-based trachoma intervention, either to monitor the progress of an existing programme or to prioritise an area for trachoma-control activities. WHO recommends that strategies aimed at disrupting the transmission of infection should be implemented based on the prevalence of trachoma in children aged 1–9 years. Interventions should be community based; individual treatment
Surgery
Corneal opacity develops in around a third of individuals who have untreated trichiasis for over a year.54 Trichiasis itself is a cause of substantial disability and reduced quality of life.55, 56 If active trachoma were to be eliminated today, a generation would still be at risk of trichiasis and unnecessary blindness. For these people, surgical intervention is currently the only effective management, and more research is needed on the best delivery of surgical programmes. WHO recommends the
Conclusion and future directions
Increasing people's standard of living and making necessary environmental improvements are the definitive interventions for active trachoma, attested to by the fact that trachoma has been eliminated from all developed cities in the world. Enhancing access to safe drinking water, adequate waste disposal, and better housing is a constructive objective for community development, irrespective of the effect on trachoma. Furthermore, such measures provide a useful link between GET 2020 (the Alliance
Search strategy and selection criteria
References (119)
- et al.
Natural history of trachomatous scarring in the Gambia: results of a 12-year longitudinal follow-up
Ophthalmology
(2001) - et al.
Inoculation of human volunteer with egg-grown inclusion conjunctivitis virus
Am J Ophthalmol
(1962) - et al.
Repeated and persistent infection with Chlamydia and the development of chronic inflammation and disease
Trends Microbiol
(1994) - et al.
The histopathology and the mechanism of entropion in patients with trachoma
Ophthalmology
(1993) - et al.
Clinical examination and laboratory tests for estimation of trachoma prevalence in a remote setting: what are they really telling us?
Lancet Infect Dis
(2005) - et al.
Field evaluation of a rapid point-of-care assay for targeting antibiotic treatment for trachoma control: a comparative study
Lancet
(2006) - et al.
Pattern of recurrence of trachomatous trichiasis after surgery: surgical technique as an explanation
Ophthalmology
(2005) - et al.
Surgery for trichiasis by ophthalmologists versus integrated eye care workers: a randomized trial
Ophthalmology
(2004) - et al.
Randomised controlled trial of single-dose azithromycin in treatment of trachoma
Lancet
(1993) - et al.
Single-dose azithromycin in the treatment of trachoma
Ophthalmology
(1996)
Infection with Chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania: a longitudinal study
Lancet
Re-emergence of Chlamydia trachomatis infection after mass antibiotic treatment of a trachoma-endemic Gambian community: a longitudinal study
Lancet
Azithromycin in control of trachoma
Lancet
Strategies for control of trachoma: observational study with quantitative PCR
Lancet
Mapping the global distribution of trachoma
Bull World Health Organ
Report of the 2nd global scientific meeting on trachoma (WHO/PBD/GET 03.1)
Global data on visual impairment in the year 2002
Bull World Health Organ
Global data on blindness
Bull World Health Organ
Risk factors for trachoma in Mali
Int J Epidemiol
Progression of active trachoma to scarring in a cohort of Tanzanian children
Ophthalmic Epidemiol
Risk factors for trichiasis in women in Kongwa, Tanzania: a case-control study
Int J Epidemiol
Incidence of trichiasis in a cohort of women with and without scarring
Int J Epidemiol
Development of chronic conjunctivitis with scarring and pannus, resembling trachoma, in guinea-pigs
Br J Ophthalmol
Chlamydial disease pathogenesis ocular hypersensitivity elicited by a genus-specific 57-kD protein
J Exp Med
Pathogenesis of trachoma: the stimulus for inflammation
J Immunol
An animal model of trachoma II: the importance of repeated reinfection
Invest Ophthalmol Vis Sci
T helper type-1 (Th1)/Th2 profiles of peripheral blood mononuclear cells (PBMC): responses to antigens of Chlamydia trachomatis in subjects with severe trachomatous scarring
Clin Exp Immunol
Immune response to chlamydial 60-kilodalton heat shock protein in tears from Nepali trachoma patients
Infect Immun
Immunopathology of trachomatous conjunctivitis
Br J Ophthalmol
Immunology of trachomatous conjunctivitis
Bull Soc Belge Ophtalmol
Temporal cytokine expression patterns in subjects with trachoma identify distinct conjunctival responses associated with infection
Clin Exp Immunol
Cytokine and fibrogenic gene expression in the conjunctivas of subjects from a Gambian community where trachoma is endemic
Infect Immun
Immunopathogenesis of conjunctival scarring in trachoma
Eye
Tryptophan depletion as a mechanism of gamma interferon-mediated chlamydial persistence
Infect Immun
Effect of interferon on a primary conjunctival epithelial cell model of trachoma
Invest Ophthalmol Vis Sci
Bactericidal activity of first-choice antibiotics against gamma interferon-induced persistent infection of human epithelial cells by Chlamydia trachomatis
Antimicrob Agents Chemother
A coding polymorphism in matrix metalloproteinase 9 reduces risk of scarring sequelae of ocular Chlamydia trachomatis infection
BMC Med Genet
Expression of growth factors in the conjunctiva from patients with active trachoma
Eye
Risk of trachomatous scarring and trichiasis in Gambians varies with SNP haplotypes at the interferon-gamma and interleukin-10 loci
Genes Immun
Conjunctival FOXP3 expression in trachoma: do regulatory T cells have a role in human ocular Chlamydia trachomatis infection?
PLoS Med
Antibody response to the 60-kDa chlamydial heat-shock protein is associated with scarring trachoma
J Infect Dis
Immunoepidemiologic profile of Chlamydia trachomatis infection: importance of heat-shock protein 60 and interferon-gamma
J Infect Dis
Morphologic and antigenic characterization of interferon-gamma mediated persistent Chlamydia trachomatis infection in vitro
Proc Nat Acad Sci USA
Hematopoietic cells are required to initiate a Chlamydia trachomatis-specific CD8+ T cell response
J Immunol
A survey of trachoma: the histopathology and the mechanism of progressive cicatrization of eyelid tissues
Ophthalmologica
Pretarsal and marginal orbicularis oculi muscle fiber changes in trachomatous cicatricial entropion: histopathological evaluation
Eur J Ophthalmol
Isolation of trachoma virus in chick embryo
J Hyg Epidemiol Microbiol Immunol
Monoclonal antibodies to Chlamydia trachomatis: antibody specifics and antigen characterization
J Immunol
Which members of a community need antibiotics to control trachoma? Conjunctival Chlamydia trachomatis infection load in Gambian villages
Invest Ophthalmol Vis Sci
Clinically active trachoma versus actual Chlamydial infection
Med J Aust
Cited by (165)
Elimination of trachoma in Algeria
2024, Bulletin de l'Academie Nationale de MedecineThe prevention and management of postoperative trachomatous trichiasis: A systematic review
2024, Survey of OphthalmologyChlamydia trachomatis
2023, Molecular Medical Microbiology, Third EditionHost Defenses to Intracellular Bacteria
2019, Clinical Immunology: Principles and Practice